Steven L Mathieu

Title: The Innovations of Steven L Mathieu

Introduction

Steven L Mathieu is an accomplished inventor based in Somerville, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neurodegenerative diseases. With a total of two patents to his name, Mathieu's work is recognized for its potential impact on medical treatments.

Latest Patents

Mathieu's latest patents focus on pyrimidine compounds and methods using the same. These inventions relate to 2-amino-4-arylpyrimidine and 2-amino-4-aryltriazine compounds, which serve as inhibitors of the heat shock protein 90 family of chaperone proteins. The patents also include pharmaceutical compositions and kits that incorporate these compounds. Furthermore, the medical applications of these inventions aim to treat disorders in subjects, particularly neurodegenerative diseases.

Career Highlights

Throughout his career, Mathieu has worked with notable organizations such as Yuma Therapeutics, Inc. and Brigham and Women's Hospital, Inc. His experience in these institutions has allowed him to collaborate with other professionals in the field and contribute to groundbreaking research.

Collaborations

Some of Mathieu's coworkers include Gregory D Cuny and Marcie A Glicksman. Their collaborative efforts have likely enhanced the development and application of his innovative compounds.

Conclusion

Steven L Mathieu's contributions to the field of pharmaceuticals through his innovative patents highlight his dedication to advancing medical science. His work has the potential to significantly impact the treatment of neurodegenerative diseases.